A novel POLD1 pathogenic variant identified in two families with a cancer spectrum mimicking Lynch syndrome.

Clicks: 181
ID: 275003
2022
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The POLD1 gene is involved in DNA proofreading to ensure accurate DNA replication. Some germline alterations in its exonuclease domain are associated with predisposition to cancers and colonic polyps. Only a few pathogenic variants have been clearly identified so far. Here we report a novel variant: c.1458G>T p.(Lys486Asn) that we classified as pathogenic, detected in two putatively unrelated families. The cancer spectrum was very similar to Lynch syndrome, implying an overlapped tissue susceptibility. The common presence of colonic polyps in carriers and the MMR proficient phenotype in tumors were distinctive features suggesting POLD1 implication. Some clinical characteristics observed in the carriers of this variant differed from those reported previously, suggesting a potential genotype/phenotype correlation, and very likely in relation to the functional importance of affected residues. Our findings provide further insight into understanding the role of POLD1 in cancer-related risk.
Reference Key
legrand2022aeuropean Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Legrand, Clémentine;Lebrun, Marine;Naïbo, Pierre;Peysselon, Magalie;Prieur, Fabienne;Kientz, Caroline;Desseigne, Françoise;Handallou, Sandrine;Rey, Jean-Marc;Nambot, Sophie;Goussot, Vincent;Hamzaoui, Nadim;Wang, Qing;
Journal European journal of medical genetics
Year 2022
DOI
S1769-7212(21)00275-5
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.